Big pharma will love this medicine as patients need to take it all the time not just for few days.
who would submit an IP and ask for a meeting with FDA if the results were great, we can fairly expect FDA to grant this one the label for quick approval as there is no approved treatment so it gets approved much quicker.
Ann: IHL-42X Phase 2 Trial Dosing Completed and pre-IND Update, page-29
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)